10 October 2007
Journal of Commercial Biotechnology
A new issue of the Journal of Commercial Biotechnology has just been posted. Drop me a line if you would like to make a submission.
Volume 13, Issue 4
- Is ‘evergreening’ a cause for concern? A legal perspective
- Exploiting the business opportunities in biotech connections: The power of social networks
- The roles and responsibilities of the EU qualified person for pharmacovigilance under Volume IXa March 2007
- Investing in new medical technologies: A decision framework
- Innovative capabilities and strategic alliances: Who is gaining what in the pharmaceutical industry?
- Industrial enzymes in bioindustrial sector development: An Indian perspective
- Fostering the process of adoption of personalised medicine: A matter of communication or a matter of cost?
- Legal and Regulatory Update
- The Economics of Biotechnology: Volumes I and II
- Global Governance of Food and Agriculture Industries
- The International Politics of Genetically Modified Food: Diplomacy, Trade and Law
- Science Business: The Promise, the Reality and the Future of Biotech
Scott Parker and Kevin Mooney
Ian P McCarthy, Leyland Pitt, Colin Campbell, Rian van der Merwe and Esmail Salehi-Sangeri
Graeme Ladds
Emma Cosh, Alan Girling, Richard Lilford, Helen McAteer and Terry Young
Marisa Ohba and Paulo N Figueiredo
Anuj Kumar Chandel, Ravinder Rudravaram, Linga Venkateswar Rao, Pogaku Ravindra and Mangamoori Lakshmi Narasu
Pedro Reinares Lara and Emma Gutierrez de Mesa
Bird & Bird and Reed Smith
Iraj Daizadeh
Alan McHughen
Robert Paarlberg
Weijun Li
The Journal of Commercial Biotechnology is online at http://www.palgrave-journals.com/jcb. If purchasing a subscription, please use subscriber code NH0707G01.
